APO-DICLOFENAC 1.5 %
DICLOFENAC SODIUM : 1.5 % · DIN 02354403 · APOTEX INC
Health Canada status: APPROVED
What is APO-DICLOFENAC?
APO-DICLOFENAC 1.5 % contains DICLOFENAC SODIUM : 1.5 %. It is listed in the Health Canada Drug Product Database under DIN 02354403, held by APOTEX INC, supplied as SOLUTION for TOPICAL administration. Health Canada currently lists it as approved, status dated 15-Jul-2010. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02354403 |
|---|---|
| Brand name | APO-DICLOFENAC |
| Generic / active ingredient | DICLOFENAC SODIUM : 1.5 % |
| Manufacturer | APOTEX INC |
| Strength | 1.5 % |
| Dosage form | SOLUTION |
| Route of administration | TOPICAL |
| Schedule | Prescription |
| ATC code | M02AA15 DICLOFENAC |
| AHFS class | 28:08.04.92 |
| Biosimilar | No |
| Health Canada status | APPROVED |
| Status date | 15-Jul-2010 |
Is DICLOFENAC in shortage in Canada?
A Canadian shortage report is on file for this molecule: Resolved — reported by PHARMA STULLN INC., last seen 04 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Other Canadian products sharing ATC code M02AA15 DICLOFENAC. 8 of 14 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| JAMP DICLOFENAC TOPICAL SOLUTION | 1.5 % | SOLUTION | JAMP PHARMA CORPORATION | MARKETED | DIN 02472309 |
| PENNSAID | 1.5 % | SOLUTION | ENDO OPERATIONS LTD. | MARKETED | DIN 02247265 |
| TARO-DICLOFENAC | 1.5 % | SOLUTION | TARO PHARMACEUTICALS INC | MARKETED | DIN 02420988 |
| VOLTAREN EMULGEL ACTIVE | 1.16 % | GEL | HALEON CANADA ULC | MARKETED | DIN 02554801 |
| VOLTAREN EMULGEL BACK & MUSCLE PAIN | 1.16 % | GEL | HALEON CANADA ULC | MARKETED | DIN 02465035 |
| VOLTAREN EMULGEL EXTRA STRENGTH | 2.32 % | GEL | HALEON CANADA ULC | MARKETED | DIN 02393190 |
| VOLTAREN EMULGEL JOINT PAIN EXTRA STRENGTH | 2.32 % | GEL | HALEON CANADA ULC | MARKETED | DIN 02465043 |
| VOLTAREN EMULGEL JOINT PAIN REGULAR STRENGTH | 1.16 % | GEL | HALEON CANADA ULC | MARKETED | DIN 02338580 |
| DICLOFENAC DIETHYLAMINE GEL EXTRA STRENGTH | 2.32 % | GEL | TARO PHARMACEUTICALS INC | APPROVED | DIN 02555263 |
| DICLOFENAC SODIUM SOLUTION | 1.5 % | SOLUTION | HIKMA CANADA LIMITED | DORMANT | DIN 02476134 |
Who else supplies DICLOFENAC worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. DICLOFENAC appears in 17208 registered pack listings across 11 markets, published on 8 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.